These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26569655)

  • 1. Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical Trials.
    Rodriguez F; Harrison RW; Wojdyla D; Mahaffey KW
    Crit Pathw Cardiol; 2015 Dec; 14(4):150-3. PubMed ID: 26569655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review.
    Fong LCW; Ford TJ; da Costa BR; Jüni P; Berry C
    J Am Heart Assoc; 2020 Jul; 9(14):e015361. PubMed ID: 32646264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.
    Campbell RT; Willox GP; Jhund PS; Hawkins NM; Huang F; Petrie MC; McMurray JJ
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27162229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.
    Akl EA; Briel M; You JJ; Sun X; Johnston BC; Busse JW; Mulla S; Lamontagne F; Bassler D; Vera C; Alshurafa M; Katsios CM; Zhou Q; Cukierman-Yaffe T; Gangji A; Mills EJ; Walter SD; Cook DJ; Schünemann HJ; Altman DG; Guyatt GH
    BMJ; 2012 May; 344():e2809. PubMed ID: 22611167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials.
    Zhang Y; Flórez ID; Colunga Lozano LE; Aloweni FAB; Kennedy SA; Li A; Craigie S; Zhang S; Agarwal A; Lopes LC; Devji T; Wiercioch W; Riva JJ; Wang M; Jin X; Fei Y; Alexander P; Morgano GP; Zhang Y; Carrasco-Labra A; Kahale LA; Akl EA; Schünemann HJ; Thabane L; Guyatt GH
    J Clin Epidemiol; 2017 Aug; 88():57-66. PubMed ID: 28583378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of consent practices in cluster randomized trials: improvements are needed in ethical conduct and reporting.
    Taljaard M; Chaudhry SH; Brehaut JC; Weijer C; Boruch R; Donner A; Eccles MP; McRae AD; Saginur R; Zwarenstein M; Grimshaw JM
    Clin Trials; 2014 Feb; 11(1):60-9. PubMed ID: 24346609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact.
    Akl EA; Briel M; You JJ; Lamontagne F; Gangji A; Cukierman-Yaffe T; Alshurafa M; Sun X; Nerenberg KA; Johnston BC; Vera C; Mills EJ; Bassler D; Salazar A; Bhatnagar N; Busse JW; Khalid Z; Walter S; Cook DJ; Schünemann HJ; Altman DG; Guyatt GH
    Trials; 2009 Jun; 10():40. PubMed ID: 19519891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation results.
    Potthoff RF
    J Biopharm Stat; 2018; 28(4):633-644. PubMed ID: 28858561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss to Follow-up in Head and Neck Cancer: A Systematic Review of Randomized Controlled Trials.
    Sawaf T; Quinton BA; Moss G; Yaffe NM; Quereshy HA; Cabrera-Aviles C; Fowler N; Li S; Thuener JE; Lavertu P; Rezaee RP; Teknos TN; Tamaki A
    Otolaryngol Head Neck Surg; 2023 Oct; 169(4):747-754. PubMed ID: 36861844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of spinal fusion and nonoperative treatment in patients with chronic low back pain: long-term follow-up of three randomized controlled trials.
    Mannion AF; Brox JI; Fairbank JC
    Spine J; 2013 Nov; 13(11):1438-48. PubMed ID: 24200413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey.
    Vervölgyi E; Kromp M; Skipka G; Bender R; Kaiser T
    BMC Med Res Methodol; 2011 Sep; 11():130. PubMed ID: 21936924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric celiac disease patients who are lost to follow-up have a poorly controlled disease.
    Barnea L; Mozer-Glassberg Y; Hojsak I; Hartman C; Shamir R
    Digestion; 2014; 90(4):248-53. PubMed ID: 25531121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care.
    Udeagu CC; Webster TR; Bocour A; Michel P; Shepard CW
    AIDS; 2013 Sep; 27(14):2271-9. PubMed ID: 23669157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
    Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
    Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment.
    Horning EL; Chen BA; Meyn LA; Creinin MD
    Contraception; 2012 Apr; 85(4):402-7. PubMed ID: 22056100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy.
    Schepens T; Morreel S; Florence E; Koole O; Colebunders R
    Int J STD AIDS; 2010 Nov; 21(11):765-9. PubMed ID: 21187359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute.
    Gordon D; Cooper-Arnold K; Lauer M
    J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up.
    Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Cochonat K; Fontier C; Guerroumi H; Yazdanpanah Y
    AIDS; 2009 Aug; 23(13):1786-9. PubMed ID: 19531927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FDA outlook of events reporting after ticagrelor or clopidogrel in the PLATO Trial: impact of sponsor censoring dates, drug discontinuation, and withdrawal of consent.
    Serebruany VL
    Cardiology; 2011; 120(3):169-71. PubMed ID: 22418766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.